Koyfin Home > Directory > Health Care > ANI Pharma Inc > Long-term Debt / Equity

ANI Pharma Inc Long-term Debt / Equity Chart (ANIP)

ANI Pharma Inc annual/quarterly Long-term Debt / Equity from 2014 to 2020.
  • ANI Pharma Inc Long-term Debt / Equity for the quarter ending June 06, 2020 was $102m a 66.41% increase of 68m year over year
  • ANI Pharma Inc Long-term Debt / Equity for the last 12 months ending June 06, 2020 was $102m a 66.41% increase of 68m year over year
  • ANI Pharma Inc Annual Long-term Debt / Equity for 2019 was $86m a 59.89% increase of 51m from 2018
  • ANI Pharma Inc Annual Long-term Debt / Equity for 2018 was $34m a -229.94% decrease of -79m from 2017
  • ANI Pharma Inc Annual Long-term Debt / Equity for 2017 was $113m a 37.28% increase of 42m from 2016
Other Ratios Metrics:
  • ANI Pharma Inc Total Debt / Capital for the quarter ending December 12, 2018 was $48m a -10.11% decrease of -5m year over year
  • ANI Pharma Inc Other Liabilities for the quarter ending December 12, 2018 was $0m a -404.03% decrease of -2m year over year
  • ANI Pharma Inc Total Debt / Equity for the quarter ending December 12, 2018 was $93m a -21.52% decrease of -20m year over year
View Chart On Koyfin

Quarterly ANIP Long-term Debt / Equity Data

06/2020$102m
03/2020$100m
12/2019$86m
09/2019$34m
06/2019$35m
03/2019$35m
12/2018$34m
09/2018$104m
06/2018$108m
03/2018$111m

Annual ANIP Long-term Debt / Equity Data

2019$86m
2018$34m
2017$113m
2016$71m
2015$71m
2014$76m
2011$-165m